Literature DB >> 11728852

Modelling suicide risk in affective disorders.

A P Boardman1, D Healy.   

Abstract

BACKGROUND: The lifetime risk of suicide in affective disorders is commonly quoted as 15%. This stems from hospital populations of affective disorders. AIMS: To model the lifetime prevalence of suicide using data on completed suicides from one English Health District and community-based rates of prevalence of affective disorders.
METHODS: A secondary analysis of a primary data set based on 212 suicides in North Staffordshire was undertaken. The population rates of psychiatric morbidity were obtained from the National Comorbidity Survey.
RESULTS: The model suggests a lifetime prevalence rate of suicide for any affective disorder at 2.4%, with a rate for those uncomplicated by substance abuse, personality disorder or non-affective psychosis at 2.4%, and a rate for uncomplicated cases who had no mental health service contact at 1.1%.
CONCLUSIONS: Lifetime prevalence rates of suicide in subgroups of affective disorders may be lower than the traditional rates cited for hospital depression. This has implications for primary care projects designed to investigate the occurrence of and the prevention of suicide.

Entities:  

Mesh:

Year:  2001        PMID: 11728852     DOI: 10.1016/s0924-9338(01)00597-1

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  8 in total

Review 1.  Antidepressants and suicide: risk-benefit conundrums.

Authors:  David Healy; Chris Whitaker
Journal:  J Psychiatry Neurosci       Date:  2003-09       Impact factor: 6.186

2.  Depression should be managed like a chronic disease: myth of 15% suicide rate was promulgated again.

Authors:  Melissa K Raven
Journal:  BMJ       Date:  2006-05-13

3.  [Depression and rheumatism: options for measuring depression].

Authors:  M Englbrecht; J Wendler; R Alten
Journal:  Z Rheumatol       Date:  2014-10       Impact factor: 1.372

4.  The impact of omega-3 fatty acids on depressive disorders and suicidality: can we reconcile 2 studies with seemingly contradictory results?

Authors:  David Mischoulon
Journal:  J Clin Psychiatry       Date:  2011-12       Impact factor: 4.384

Review 5.  'Atypical' antidepressants in overdose: clinical considerations with respect to safety.

Authors:  Nicholas A Buckley; Thomas A Faunce
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

6.  Modeling of the temporal patterns of fluoxetine prescriptions and suicide rates in the United States.

Authors:  Michael S Milane; Marc A Suchard; Ma-Li Wong; Julio Licinio
Journal:  PLoS Med       Date:  2006-06-13       Impact factor: 11.069

7.  A Novel Cosegregating DCTN1 Splice Site Variant in a Family with Bipolar Disorder May Hold the Key to Understanding the Etiology.

Authors:  André Hallen; Arthur J L Cooper
Journal:  Genes (Basel)       Date:  2020-04-18       Impact factor: 4.096

8.  Long-term suicide risk in no, one or more mental disorders: the Lundby Study 1947-1997.

Authors:  C Holmstrand; M Bogren; C Mattisson; L Brådvik
Journal:  Acta Psychiatr Scand       Date:  2015-09-24       Impact factor: 6.392

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.